Literature DB >> 15207083

[The induction of differentiation into dendritic cells from HL-60 cells by calcium ionophore].

Jun Wu1, Tai-cheng Yang, Jiang Xian, Jie Wang, Zheng-liang Chen, Ning Fu.   

Abstract

AIM: To explore whether the promyelocytic leukemia cell line HL-60 may differentiate into activated dendritic cells (DCs) by A23187, a calcium ionophore.
METHODS: The HL-60 cells were cultured in common medium alone or with various concentrations of A23187 (25-1 600 microg/L) and rhGM-CSF (100 microg/L). After culture for 24-96 hours, the cellular morphological change was observed under light microscope and electron microscope. Surface makers on treated HL-60 cells were analyzed by flow cytometry. The proliferation of allogeneic human T cells was detected by MTT colorimetry.
RESULTS: Under the condition of a suitable dose (200 microg/L) of A23187 treatment of HL-60 cells for 24 hours, the expression of CD83 molecule, a characteristic marker on DCs, was highest. The typical dendritic outgrowth appeared at a time when HL-60 cells were treated with A23187 for 72 hours. However, when HL-60 cells were treated with A23187 for 96 hours, the expressions of CD80 (B7.1), CD86 (B7.2), MHC-class II molecule and CD54 on HL-60 cells reached peak, and marked activation of allogeneic T cells occurred.
CONCLUSION: Calcium ionophore A23187 can induce the HL-60 cells to differentiate into activated DCs-like cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15207083

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  2 in total

Review 1.  The characterization and role of leukemia cell-derived dendritic cells in immunotherapy for leukemic diseases.

Authors:  Changjin Yuan; Guanhua Song; Guosheng Jiang
Journal:  Intractable Rare Dis Res       Date:  2012-05

2.  Interrogating the recognition landscape of a conserved HIV-specific TCR reveals distinct bacterial peptide cross-reactivity.

Authors:  Juan L Mendoza; Suzanne Fischer; Marvin H Gee; Lilian H Lam; Simon Brackenridge; Fiona M Powrie; Michael Birnbaum; Andrew J McMichael; K Christopher Garcia; Geraldine M Gillespie
Journal:  Elife       Date:  2020-07-27       Impact factor: 8.140

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.